Vinblastine sulfate salt
SIGMA/V1377 - ≥97% (HPLC)
Synonym: VLB; Vincaleukoblastine sulfate salt
CAS Number: 143-67-9
Empirical Formula (Hill Notation): C46H58N4O9 · H2SO4
Molecular Weight: 909.05
EC Number: 205-606-0
MDL Number: MFCD00082457
Linear Formula: C46H58N4O9 · H2SO4
Product Type: Chemical
absorption | 14 at 270 nm in 0.1 M phosphate buffer at 1 mM |
16.2 at 259 nm in ethanol at 1 mM | |
53.7 at 214 nm in ethanol at 1 mM | |
antibiotic activity spectrum | neoplastics |
assay | ≥97% (HPLC) |
color | white to light yellow |
form | (powder or amorphous or crystalline powder) |
InChI | 1S/C46H58N4O9.H2O4S/c1-8- |
InChI key | KDQAABAKXDWYSZ-PNYVAJAMSA |
mode of action | DNA synthesis | interferes |
mp | 267 °C (dec.) (lit.) |
originator | Eli Lilly |
Quality Level | 200 |
SMILES string | OS(O)(=O)=O.[H][C@@]12CN( |
storage temp. | 2-8°C |
Application: | Vinblastine sulfate salt has been used: • as a microtubule depolymerizing drug for the synchronization of human cell lines in G2/M phase • as a multidrug resistance screening substrate in human colon cancer cell line (HCT116) cell line • as an antimicrotubule agent in sub perineural glia of Drosophila brain |
Biochem/physiol Actions: | Plant alkaloid that inhibits microtubule assembly by binding tubulin and inducing self-association in spiral aggregates in a reaction that appears to be regulated by the C-terminus of β-tubulin and is enhanced by GDP and GTP. Depolymerizes microtubules. Arrests the cell cycle in G2/M-phase by blocking mitotic spindle formation. Triggers Raf-1 activation, phosphorylation of bcl-2-family proteins, induction of p53 expression, and apoptosis in several tumor cell lines. Substrate of Pgp and CYP3A4. |
Features and Benefits: | This compound is a featured product for ADME Tox research. Click here to discover more featured ADME Tox products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm . |
Features and Benefits: | This compound was developed by Eli Lilly . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
Symbol | GHS07,GHS08 |
Signal word | Warning |
Hazard statements | H302 - H341 - H361fd |
Precautionary statements | P201 - P301 + P312 + P330 - P308 + P313 |
Hazard Codes | Xn |
Risk Statements | 22-37/38-41 |
Safety Statements | 26-36/39 |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Purity | ≥97% (HPLC) |
mp | 267 °C (dec.) (lit.) |
Storage Temp. | 2-8°C |
UNSPSC | 12352200 |